Skip to main navigation Skip to search Skip to main content

Increased incidence of gestational diabetes in women receiving prophylactic 17α-hydroxyprogesterone caproate for prevention of recurrent preterm delivery

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)72-74
Number of pages3
JournalObstetrical and Gynecological Survey
Volume63
Issue number2
DOIs
StatePublished - Feb 2008

Cite this